• Selvita to acquire Fidelta from Galapagos

    Tuesday November 24th 2020

  • Qarad opent nieuw kantoor in VK

    Tuesday November 24th 2020

  • argenx enters into agreement to acquire Priority Review Voucher

    Monday November 23rd 2020

  • Aphea.Bio secures €14 million Series B financing to further develop its next generation agricultural biologicals

    Friday November 20th 2020

  • E4/DRSP, a novel combined oral contraceptive, submitted to Brazilian regulatory authorities

    Tuesday November 17th 2020

  • Biocartis announces publication of large multi-center comparison study with Idylla™ MSI Assay showing very low failure rates and excellent concordance with reference methods

    Tuesday November 17th 2020

  • icometrix wins EIT Digital Challenge 2020 for Digital Wellbeing

    Tuesday November 17th 2020

  • AbolerIS Pharma raises €2.5M in seed financing from Turenne Santé/Sham Innovation Santé and Newton Biocapital

    Tuesday November 17th 2020

  • Your news here?

  • Mithra signs license and supply agreement for commercialization of Myring™ in Venezuela

    Tuesday November 10th 2020

  • Biocartis announces CE-marking of its fully automated Idylla™ SARS-CoV-2 test

    Tuesday November 10th 2020

  • First patient dosed with GLPG3667 in psoriasis patient Phase 1b trial

    Tuesday November 10th 2020


Strategic Partners